期刊文献+

新活素治疗伴胸腔积液心衰的短期观察 被引量:2

Short Term Observation of rh-BNP for Treatment of Pleural Effusion with Heart Failure
下载PDF
导出
摘要 目的:探讨应用新活素对伴有胸腔积液的心衰患者短期应用的临床疗效。方法:选用24例心衰伴胸腔积液的临床患者。随机分为治疗组与对照组,对照组给予常规抗心力衰竭治疗,治疗组在对照组的基础上联合应用新活素为期7d的短期治疗,观察治疗前后的临床效果。结果:1周后两组心功能、NT-proBNP、胸片及临床症状相比较,差异均具有统计学意义(P<0.05)。结论:对于心衰伴有胸腔积液的患者,应用新活素进行治疗效果确切,值得临床推广使用。 Objective:To investigate the clinical efficacy of the short-term application of rh-BNP for treatment of pleural effusion with heart failure.Methods:24 cases of heart failure with pleural effusion were selected.They were patients treated.They were randomly divided into treatment and control groups.The control group was given conventional anti-failure therapy,while the treatment group was given a 7d treatment applying rh-BNP based on the control group.The clinical effects before and after treatment were observed.Results:After one week,the cardiac function,NT-proBNP,chest radiograph and clinical symptoms of the two groups were compared.The differences were statistically significant(P〈0.05).Conclusion:For patients with pleural effusion associated with heart failure,the application of rh-BNP for treatment is worth to promote the clinical use.
出处 《亚太传统医药》 2012年第8期118-119,共2页 Asia-Pacific Traditional Medicine
关键词 心力衰竭 新活素 胸腔积液 心功能 NT-PROBNP Heart Failure rh-BNP Pleural Effusion Heart Function NT-proBNP
  • 相关文献

参考文献8

二级参考文献31

  • 1蒋涛,李德才,刘思泰,唐焕君,李健,凌云.1998,2001和2004年绵阳市慢性心力衰竭住院患者药物治疗动态分析[J].四川医学,2006,27(6):598-600. 被引量:19
  • 2付尧,杨光,白小涓,贾大林,马玉龙,齐国先.重组人脑利钠肽治疗充血性心力衰竭的疗效评价[J].中国医科大学学报,2006,35(2):191-192. 被引量:35
  • 3中华人民共和国.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002:162
  • 4Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart, production in the ventricle [J]. Hypertension, 1997, 17: 1152-1156.
  • 5Mc Donagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left ventricular systolic dysfunction [J]. Lancet, 1998, 35: 9-13.
  • 6Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting [J]. J Am Coll Cardiol, 20010 37: 379-385.
  • 7Troughton RW, Frampton CM, Yandle T, et al. Treatment of heart failure guided by plasma N- BNP concentrations [J].Lancet, 2000, 355 (9210): 1126.
  • 8Yamamoto K, Burnett JC, Jougasaki M, et al. Superiority of BNP as a hormonal maker of ventricular systolic and diastolic dysfunction and ventricular hypertropgy [J]. Hypertension, 1996, 28 (6): 988.
  • 9Maeda K, Tsutarnoto T, Wada A, et al. High level of plasma brain natriuretic peptide and interleukin- 6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure [J]. J AM Coll Cardiol, 2000, 36 (5): 1587.
  • 10Cynthuia MB, Pasqualina S, R9bert M, et al. Physiological, pathological, pharmacological, biochemical and hematologica factors affecting BNP and NT - proBNP [ J ]. Clinical Biochemistry, 2008, 41:231 -239.

共引文献83

同被引文献13

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部